Efficacy results of spontaneous and magnet-activated adjunctive vagus nerve stimulation (VNS) therapy in children <=12 years with pharmacoresistant epilepsy

被引：0

作者：

Zwolinski, P. ^{[1
]}

Roszkowski, M. ^{[1
]}

机构：

[1] Mem Child Hosp, Dept Neurosurg, Warsaw, Poland

来源：

EPILEPSIA | 2007年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：117 / 118

页数：2

共 27 条

[1] Adjunctive vagus nerve stimulation (VNS) therapy for children up to 6 years of age with pharmacoresistant epilepsy: Long-term efficacy, safety and magnet use
Roszkowski, M.
Zwolinski, P.
EPILEPSIA, 2007, 48 : 39 - 40
[2] Adjunctive vagus nerve stimulation (VNS) therapy for patients with pharmacoresistant epilepsy and learning disabilities
Bird, Jonathan
Kwok, D.
Khairullah, S.
EPILEPSIA, 2007, 48 : 12 - 12
[3] Vagus nerve stimulation (VNS) therapy for the treatment of pharmacoresistant epilepsy in children ≤6 years:: Efficacy and quality of life (QOL) results
Van Woensel, R. D. C.
Verstappen, D.
Hosten, S.
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 83 - 84
[4] Adjunctive vagus nerve stimulation (VNS) therapy for the treatment of pharmacoresistant epilepsy in two children with Angelman syndrome
Vasconcelos, M. M.
Van Woensel, R. D. C.
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 92 - 92
[5] Long-term results of adjunctive vagus nerve stimulation (VNS) therapy for the treatment of pharmacoresistant epilepsy in children and adolescents under 18 years of age
Zwolinski, Piotr
Roszkowski, M.
EPILEPSIA, 2007, 48 : 39 - 39
[6] Efficacy and quality of life data in patients with pharmacoresistant epilepsy treated with adjunctive Vagus Nerve Stimulation (VNS) therapy:: Experience in Venezuela
Soto, Arnoldo
Duran, F.
Rincon, J.
Marques, A.
Marques, I.
Scholtz, H.
Rey, J.
Contreras, G.
Sainz, V.
Pernia, E.
Faoro, A.
Rangel, L. M.
EPILEPSIA, 2007, 48 : 70 - 71
[7] Vagus nerve stimulation (VNS) therapy for the treatment of pharmacoresistant epilepsy:: The Spanish experience
Navarrete, Eduardo Garcia
Moro, R. C.
Garcia, M. N.
Sola, R. G.
EPILEPSIA, 2007, 48 : 127 - 127
[8] Vagus nerve stimulation (VNS) therapy for the treatment of patients with cavernous angiomas and pharmacoresistant epilepsy
Zwolinski, P.
Van Woensel, R.
Roszkowski, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 223 - 223
[9] Vagus nerve stimulation (VNS) therapy for the treatment of pharmacoresistant epilepsy associated with hypothalamic hamartomas
Roobroeck, Ron
Zwolinski, P.
Van Woensel, R.
EPILEPSIA, 2007, 48 : 146 - 146
[10] Vagus nerve stimulation (VNS) therapy for the treatment of pharmacoresistant epilepsy assiociated with hypothalamic hamartomas
Zwolinski, P.
Van Woensel, R.
Roszkowski, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 93 - 94

← 1 2 3 →

Efficacy results of spontaneous and magnet-activated adjunctive vagus nerve stimulation (VNS) therapy in children &lt;=12 years with pharmacoresistant epilepsy

Efficacy results of spontaneous and magnet-activated adjunctive vagus nerve stimulation (VNS) therapy in children <=12 years with pharmacoresistant epilepsy